Inve US ▾
OTOTF

Blue Owl Technology Finance (OTF) Q2 FY26 earnings call: guidance and Q&A

Earnings call· Jun 2026 (Q2 FY26)· Financials· Aug 6, 2026

Source: earnings call transcript

Executive summary

Blue Owl Technology Finance Corp. Q2 FY26 — Stable NAV, Earnings Growth, and Strong Credit Quality

Blue Owl Technology Finance Corp. delivered a strong quarter, marked by stable net asset value, continued earnings growth, and excellent credit quality, with nonaccruals remaining exceptionally low. The company strategically enhanced its capital structure and is well-positioned to capitalize on an improving investment environment characterized by wider spreads and stronger protections. Despite a market valuation disconnect, management is confident in its path to dividend coverage by mid-next year through leverage ramp, equity portfolio rotation, and disciplined deployment.

Highlights

5
  • Adjusted Net Investment Income (NII) per share increased to $0.30, supported by continued deployment and growth in net leverage.

  • Net Asset Value (NAV) per share remained stable at $16.48.

  • Nonaccrual rates were among the lowest in the industry at just 10 basis points at fair value ($20 million).

  • Strengthened capital structure by issuing a $500 million unsecured bond, adding $150 million of secured financing, and extending the $2.7 billion revolving credit facility.

  • Repurchased over $55 million of stock this quarter, contributing to $170 million in total repurchases over the past three quarters.

Concerns

3
  • Market valuation has not reflected the underlying performance, implying nearly $3 billion of credit losses or approximately 40% portfolio defaults.

  • Software deal activity remains slower, though the company is finding differentiated opportunities.

  • PIK income declined from 13.1% last quarter to approximately 12.5% of total investment income this quarter.

Guidance & targets

CategoryTargetConfidence
Base dividend coverage
Cover base dividend
high materiality
High
Net leverage
Midpoint of 0.9x to 1.25x range
high materiality
High
Share repurchase program authorization
$195 million remaining
medium materiality
High

OTF operating KPIs by quarter

OTF operating KPIs stated on its earnings calls, by fiscal quarter
KPI Mar 2026 Q1 FY26This call Jun 2026 Q2 FY26Change vs prior quarter
Portfolio company revolver utilization rate
<10% Amendments remained similarly light with no pickup in material amendment activity and portfolio company revolver utilization remained consistent with historical levels at just under 10%. Source: earnings call transcript
~10% Amendment activity remains light and portfolio company revolver utilization remained consistent with historical levels at approximately 10%. Source: earnings call transcript
—
Employees Technology investment
40 Our 40-person dedicated technology investment team maintains a constant dialogue with portfolio companies, sponsors and industry experts as they adapt to the changing landscape and deploy additional resources. Source: earnings call transcript
40 Our 40-person dedicated technology investing team maintains ongoing dialogue with management teams, sponsors and industry experts, giving us differentiated real-time insight into how businesses are adapting to AI. Source: earnings call transcript
0%
New investment commitments
$1.7B On the originations side, we entered the quarter with a strong pipeline, which converted into $1.7 billion of new commitments and funded $1.3 billion. Source: earnings call transcript
~$850M In the second quarter, we made approximately $850 million of new commitments and funded $550 million. Source: earnings call transcript
—
Funded investment commitments
$1.3B On the originations side, we entered the quarter with a strong pipeline, which converted into $1.7 billion of new commitments and funded $1.3 billion. Source: earnings call transcript
$550M In the second quarter, we made approximately $850 million of new commitments and funded $550 million. Source: earnings call transcript
-57.7%

Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.

Deals & partnerships

Caris Platform-wide loan for cancer diagnostics company $700 million

Blue Owl led a $700 million platform-wide loan for Caris, a commercial stage company focused on next-generation cancer diagnostics. This highlights Blue Owl's deep sector expertise and dedicated life sciences credit and royalty team.

Risks & headwinds

Market valuation disconnect Current

Implies nearly $3 billion of credit losses or approximately 40% of the portfolio defaults, contrasting with actual nonaccruals of 10 basis points ($20 million).

Mitigation:Continued share repurchase activity, focus on strong portfolio performance, expectation for technical selling pressure from lockup releases to ease over time, and communication of underlying value.

Slower software deal activity Near-term

Deal activity remains subdued.

Mitigation:Finding differentiated opportunities across other areas of technology with deep expertise and strong platform connectivity, including life sciences and digital infrastructure. Prioritizing high-quality opportunities with familiar borrowers.

AI disruption concerns Ongoing

Initial broad-based AI concerns.

Mitigation:Investors are increasingly distinguishing between businesses vulnerable to AI disruption and those built around mission-critical platforms. OTF's portfolio is concentrated in durable market segments positioned to benefit from AI integration, with borrowers generating high single-digit revenue and EBITDA growth. Sponsors are investing significant resources in AI enablement across portfolio companies.

What to watch in Q3 FY26

Base dividend coverage

Mid-next year
Current Not yet covered (implied)
Target Covered

Why it matters

Achieving base dividend coverage is a key milestone for shareholder returns and valuation.

OTF has a clear path towards dividend coverage by the middle of next year.

Find out whether OTF delivers this. Inve re-checks your case every morning.

Q&A highlights

What are the primary drivers for earnings growth towards the $0.35 target, and how should we think about the growth and returns from the life sciences program?

Management identified four drivers: increasing leverage from 0.93x, improved deployment economics with wider spreads (150-200 bps wider for software), repricing of existing loans below S+500 (approx. $4.7B), and rotation of non-income-producing equity (7% of portfolio, e.g., potential $125M gain from remaining SpaceX stake). The life sciences JV is a stable, consistent dividend producer, with recent repayment activity being normal course.

“there are really 4 primary drivers to drive earnings towards the $0.35, the biggest one being leverage, we're about 0.93 turns, which is the low end of the target range.”

asked by Finian O'Shea · answered by Erik Bissonnette

2 min read 6 chapters

Detailed narrative

Strong Q2 Performance and Credit Quality

Blue Owl Technology Finance Corp. reported a robust second quarter with adjusted net investment income of $0.30 per share and a stable net asset value of $16.48 per share. The portfolio demonstrated excellent credit quality, maintaining nonaccrual rates at a low 10 basis points at fair value.

This performance is attributed to the underlying strength of borrowers, who continue to generate steady organic growth in revenues and EBITDA, with no material signs of stress observed.

Strategic Capital Structure Enhancements

During the quarter, OTF significantly strengthened its capital structure amidst a challenging market. The company successfully issued a $500 million unsecured bond, secured an additional $150 million in secured financing, and extended the maturity of its $2.7 billion revolving credit facility.

These actions addressed all 2026 maturities, preserved the unsecured funding mix, and resulted in affirmed investment-grade ratings from all credit rating agencies, providing over $2 billion in total liquidity and capacity.

Optimistic Investment Environment Outlook

Management expressed optimism regarding OTF's positioning, citing a more attractive investment environment for technology. Reduced capital availability has led to wider spreads and stronger protections for lenders. Higher forward rate expectations are anticipated to provide a tailwind for the predominantly floating-rate loan portfolio.

Additionally, the market conversation around software is becoming more balanced, distinguishing resilient businesses from those vulnerable to AI disruption, aligning with OTF's investment strategy.

Portfolio Deployment and Diversification

The company made steady progress in ramping its portfolio, with approximately $850 million in new commitments and $550 million funded during the quarter. While software activity remains muted, OTF is finding differentiated opportunities in digital infrastructure and life sciences. Life sciences now represents nearly 2% of the portfolio, highlighted by a $700 million platform-wide loan for Caris, a commercial-stage cancer diagnostics company, leveraging Blue Owl's deep sector expertise.

Shareholder Value and Market Disconnect

OTF's NAV per share was supported by portfolio write-ups and accretion from share repurchases, with over $55 million bought back this quarter and $170 million over the past three quarters. Despite strong performance, management noted a significant disconnect with the market valuation, which implies substantial credit losses not reflected in the actual portfolio's health.

The company believes easing technical selling pressure from fully unlocked shares and continued performance will eventually close this valuation gap.

Path to Enhanced ROE and Dividend Coverage

Management outlined clear drivers to improve Return on Equity (ROE) and achieve base dividend coverage by mid-next year. These include increasing net leverage towards the midpoint of the target range, rotating non-income-producing equity investments (like the remaining SpaceX position) into income-generating assets, and deploying capital into the current attractive environment with wider spreads and higher base rates.

This strategy aims to expand ROE while maintaining a disciplined underwriting approach.

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.